Skip to main content
. 2023 Dec 8;7(2):115–119. doi: 10.1002/iju5.12679

Fig. 3.

Fig. 3

Magnetic resonance imaging of recurrent pelvic floor tumor before olaparib administration. The tumors show faintly high signal intensity on T2‐weighted images and are diffusion‐weighted image‐positive.